By Drug Class / Mechanism

Beta-Lactam Antibiotics Market Analysis

Cross-industry research covering Beta-Lactam Antibiotics across 1 market reportspanning Pharmaceuticals.

1 Reports

1 Industries

Reports Covering Beta-Lactam Antibiotics

Hospital Acquired Infection Control Market to Reach USD 41.6B by 2033 at 6.4% CAGR

Pharmaceuticals·Market: USD 25.3 Billion (2025)·CAGR: 6.4%

Penicillins, cephalosporins, and carbapenems collectively represent the highest-volume antimicrobial class in hospital formularies worldwide. Piperacillin-tazobactam remains the workhorse of broad-spectrum gram-negative HAI prophylaxis (nct:NCT06123169), though carbapenem stewardship pressure is shifting prescribing patterns toward cephalosporin-avibactam combinations in ESBL settings.

29%

Market Share

5.6%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments